Tony Milando is an accomplished C-suite executive with more than 30 years of experience in consumer and industrial verticals.  Tony has successfully led cross-functional teams in manufacturing, supply chain, continuous improvement, and mergers and acquisitions.  For the past 8 years, he has reported directly to the CEO of Xylem, Inc (NYSE: XYL), a $7 billion global water technology company. Tony regularly advised the Board on supply chain strategy, manufacturing operations, and acquisition planning and integration. Tony also represented Xylem at investor conferences.

From 2001, Tony led large-scale global procurement and operations organizations. He consistently delivered upper-quartile procurement savings, substantially expanded low-cost sourcing, dramatically improved facility safety records and drove improved working capital. 

Tony has developed deep expertise in M&A due diligence and integration.  He co-led Stanley’s merger with Black & Decker, delivering more than $500m of annualized cost synergies and in 2023, led the integration of Xylem’s $7.5billion acquisition of Evoqua Water Technologies.

Throughout his career, Tony has had a reputation of being a resonant leader who consistently created strong followership of enterprise thinkers and deep alignment with key stakeholders.   His legacy are the high performing empowered teams he developed and nurtured.   

He currently serves on the Board of the Greater Baltimore Medical Center - a $500 million not-for-profit health care system and on the Advisory Board of Assert AI – a computer vision company.

Tony earned a BS in Accounting and Finance from Towson University and an MBA from Loyola University. He is a CPA and an adjunct professor at Towson University. He currently resides in Maryland.